NOXXON Pharma NV (EURONEXT:ALNOX)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - ALNOX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ALNOX
- Market Cap€22.000m
- SymbolEURONEXT:ALNOX
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINNL0012044762
Company Profile
NOXXON Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment. All its product candidates are based on a new class of drug called Spiegelmers, which are identified and synthesized through a proprietary discovery platform which the Group believes offers specific advantages over other drug classes. All operational activities are conducted in Berlin.NOXXON Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment.
Latest ALNOX news
Currently there for this company. Visit our news hub for other news .